Comparative study of eosinophil chemotaxis, adhesion, and degranulation in vitro in ulcerative colitis and Crohn's disease

Inflammatory Bowel Diseases

Volumn 13, Issue 2, 2007, Pages 211-218

  Coppi, Luciane C ^a   Thomazzi, Sara M ^a   Ayrizono, Maria De Lourdes S ^a   Coy, Claudio S R ^a   Fagundes, Joao J ^a   Goes, Juvenal R N ^c   Franchi Jr , Gilberto C ^a   Nowill, Alexandre E ^a   Monies, Ciro G ^a   Antunes, Edson ^a   Ferraz, Jose Geraldo P ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF CALGARY   (Canada)

^c NONE

Author keywords

Crohn's disease; Eosinophil; Inflammation; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

CD11B ANTIGEN; EOSINOPHIL PEROXIDASE; FIBRONECTIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; CELL ADHESION; CELL STRUCTURE; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DEGRANULATION; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULCERATIVE COLITIS;

CELL ADHESION; CELL DEGRANULATION; CHEMOTAXIS; COLITIS, ULCERATIVE; CROHN DISEASE; EOSINOPHIL PEROXIDASE; EOSINOPHILS; FEMALE; FIBRONECTINS; HUMANS; IMMUNOLOGIC FACTORS; INTEGRIN ALPHA4BETA1; MACROPHAGE-1 ANTIGEN; MALE; MICROSCOPY, ELECTRON;

EID: 34249333049     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20018     Document Type: Article

References (46)

1. Dignass AU, Baumgart DC, Sturm A. The aetiopathogenesis of inflammatory bowel disease - immunology and repair mechanisms. Aliment Pharmacol Ther. 2004;209(suppl 4):9-17.
2. Allez M, Mayer, L. Regulatory T cells - peace keepers in the gut. Inflamm Bowel Dis. 2004;10:666-676.
3. Adams D, Eksteen B. Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease. Nat Rev Immunol. 2006;6:244-251.
4. Maloy KJ, Antonelli LRV, Lefevre M, Powrie F. Cure of innate intestinal immune pathology by CD4+CD25+ regulatory T cells. Immunol Lett. 2005;97:189-192.
5. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med. 200; 192:295-302.
6. Van den Brande JM, Braat H, Van den Brink GR, et al. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterol. 2003;124:1774-1785.
7. Marini M, Barnias G, Rivera-Nieves J, et al. TNF-α neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis. Proc Natl Acad Sci U S A. 2003;100: 8366-8371.
8. Saverymuttu SH, Peters AM, Lavender JP, et al. In vivo assessment of granulocyte migration to diseased bowel in Crohn's disease. Gut 1985; 26:378-383.
9. Bischoff SC, Wedemeyer J, Herrmann A, et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology. 1996;28:1-13.
10. Scholmerich J, Schmidt E, Schumichen C, et al. Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m hexamethyl propylene amine oxine as leukocyte label. Gastroenterol. 1988;95:1287-1293.
11. Carvalho ATP, Elia CCS, Souza HSP, et al. Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease. J Clin Gastroenterol. 2003;36:120-125.
12. Jeziorska M, Haboubi N, Schofield P, et al. Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemmical technique. J Pathol. 2001;194:484-492.
13. Reinecker HC, Steffen M, Witthoeft T, et al. Enhanced secretion of tumor necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol. 1993;94:174-181.
14. Berstad A, Borkje B, Riedel B, et al. Increased fecal eosinophil cationic protein in inflammmatory bowel disease. Hepato-Gastroenterol. 1993; 40:276-278.
15. Levy AM, Gleich GJ, Sandborn WJ, et al. Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease. Mayo Clin Proc. 1997;72:117-123.
16. Raab Y, Fredens K, Gerdin B, et al. Eosinophil activation in ulcerative colitis. Studies on mucosal release and localization of eosinophil granule constituents. Dig Dis Sci. 1998;43:1061-1070.
17. Giembycz MA, Lindsay MA. Pharmacology of the eosinophil. Pharmacological Rev. 1999;51:213-339.
18. Hansel TT, De Vries IJM, Iff T, et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991;145:105-110.
19. Hakansson L, Nielsen LS, Teder P. Measurement of neutrophil and eosinophil adhesion to E-selectin, VCAM-1, and ICAM-1 by the use of transfected fibroblast cell lines. J Immunol Methods 1994;176(1):53-66.
20. Nagata M, Sedgwick JB, Bates ME, et al. Eosinophil adhesion to vascular cell adhesion molecule-1 activates superoxide anion generation. J Immunol. 1995;155:2194-2202.
21. Richards KL, McCullough J. A modified microchamber method for chemotaxis and chemokinesis. Immunol Commun. 1984;13:49-62.
22. Kroegel C, Yukawa T, Dent G, et al. Stimulation of degranulation from eosinophils by platelet activating factor . J Immunol. 1989;142:3518-3526.
23. Forbes E, Murase T, Yang M, et al. Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase. J Immunol. 2004;172:5664-5675.
24. Kald B, Olaison G, Sjodahl R, et al. Novel aspect of Crohn's disease: increased content of platelet-activating factor in ileal and colonic mucosa. Digestion 1990;46(4):199-204.
25. Mitsuyama K, Toyonaga A, Sasaki E, et al. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin Exp Immunol. 1994;96:432-436.
26. Dubucquoi S, Janin A, Klein O, et al. Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease. Gut 1995; 37(2):242-246.
27. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, et al. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med. 1996;2:449-456.
28. Berrebi D, Banerjee A, Paris R, et al. In situ Rantes and interferon-gamma gene expression in pediatric small bowel Crohn's disease. J Pediatr Gastroenterol Nutr. 1997;25:371-376.
29. Walsh GM, Symon FA, Wardlaw AJ. Human eosinophils preferentially survive on tissue fibronectin compared with plasma fibronectin. Clin Exp Allergy 1995;25:1128-1136.
30. Egesten A, Gullberg U, Olsson I, et al. Phorbol ester-induced degranulation in adherent human eosinophil granulocytes is dependent on CD11/ CD18 leukocyte integrins. J Leukoc Biol. 1993;53:287-293.
31. Dalton SL, Scharf E, Briesewitz R, et al. Cell adhesion to extracellular matrix regulates the life cycle of integrins. Mol Biol Cell 1995;6:1781-1791.
32. Stewart M, Hogg N. Regulation of leukocyte integrin function: affinity vs. avidity. J Cell Biochem. 1996;61:554-561.
33. Bazzoni G, Hemler ME. Are changes in integrin affinity and conformation overemphasized? Trends Biochem Sci. 1998;23(1):30-34.
34. Faull RJ, Kovach NL, Harlan JM, et al. Affinity modulation of integrin alpha 5 beta 1: regulation of the functional response by soluble fibronectin. J Cell Biol. 1993;121(1):155-162.
35. Conran N, Ferreira HHA, Lorand-Metze I, et al. Nitric oxide regulates human eosinophil adhesion mechanisms in vitro by changing integrin expression and activity on the eosinophil cell surface. Br J Pharmacol. 2001;134:632-638.
36. Ezeamuzie CI, Al-Hage M. Differential effects of salbutamol and salmeterol on human eosinophil responses. J Pharmacol Exp Ther. 1998; 284(1):25-31.
37. Thomazzi SM, Ferreira HH, Conran N, et al. Role of nitric oxide on in vitro human eosinophil migration. Biochem Pharmacol. 2001;62:1417-1421.
38. Thomazzi SM, Moreira J, Marcondes S, et al. Role of cyclic GMP on inhibition by nitric oxide donors of human eosinophil chemotaxis in vitro. Br J Pharmacol. 2004;141:653-660.
39. Kimura H, Hokari R, Miura S, et al. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut 1998;42(2): 180-187.
40. Kernen P, Wymann MP, von Tscharner V, et al. Shape changes, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils. J Clin Invest. 1991;87:2012-2017.
41. White SR, Strek ME, Kulp GV, et al. Regulation of human eosinophil degranulation and activation by endogenous phospholipase A2. J Clin Invest. 1993;91:2118-2125.
42. Jeziorska M, Haboubi N, Schofield P, et al. Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemical technique. J Pathol. 2001;194:484-492.
43. Carlson M, Raab Y, Peterson C, et al. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion. Am J Gastroenterol. 1999; 94:1876-1883.
44. Wu W, Chen Y, Hazen SL. Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem. 1999; 274:25933-25944.
45. MacPherson JC, Comhair SA, Erzurum SC, et al. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol. 2001;166:5763-5772.
46. Kruidenier L, Kuiper I, Van Duijn W, et al. unbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol. 2003;201(1):17-27.